LBX2 and ovarian cancer: MiR‐490‐5P prevents HCC metastasis by mediating the downregulation of E2F2 and ECT2,27 while LBX2‐AS1 has been shown to enhance E2F2 gene expression to promote ovarian cancer progression.28